Abstract
Data concerning circulating immune complexes were obtained for women who had had a pulmonary embolism, myocardial infarction, or cerebral thrombosis, and for 224 healthy controls. In women with pulmonary embolism who had used oral contraceptives concentrations of circulating immune complexes were significantly higher than in healthy controls (regardless of oral contraceptive use), or in those with pulmonary embolism who had never used these preparations. Concentrations of circulating immune complexes were not raised in myocardial infarction, but these women had major risk factors for ischaemic heart disease. The group of patients with cerebral thrombosis without risk factors tended to have high concentrations of circulating immune complexes. The data provide some confirmation that immunological mechanisms may play a role in thrombotic episodes associated with oral contraceptives, especially when they occur in the absence of risk factors for vascular disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beaumont J. L., Lemort N., Beaumont V., Edouard L. Détection des anticorps anti-éthinyl-oestradiol induits par les contracetifs oraux. Ann Biol Clin (Paris) 1981;39(2):69–74. [PubMed] [Google Scholar]
- Beaumont J. L., Lemort N., Lorenzelli-Edouard L., Delplanque B., Beaumont V. Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol. 1979 Dec;38(3):445–452. [PMC free article] [PubMed] [Google Scholar]
- Beaumont J. L., Lemort N. Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG. Clin Exp Immunol. 1976 Jun;24(3):455–463. [PMC free article] [PubMed] [Google Scholar]
- Beaumont V., Lemort N., Beaumont J. L. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol. 1982 Feb;2(1):8–12. doi: 10.1111/j.1600-0897.1982.tb00077.x. [DOI] [PubMed] [Google Scholar]
- Beaumont V., Lemort N., Lorenzelli L., Mosser A., Beaumont J. L. Hormones contraceptives, risque vasculaire et précipitabilité anormale des gamma-globulines sériques. Pathol Biol (Paris) 1978 Dec;26(9-10):531–537. [PubMed] [Google Scholar]
- Beaumont V., Lorenzelli-Edouard L., Lemort N., Beaumont J. L. Detection and composition of circulating immune complexes in oral contraceptive users. Biomedicine. 1979 Nov;30(5):256–260. [PubMed] [Google Scholar]
- Irey N. S., Manion W. C., Taylor H. B. Vascular lesions in women taking oral contraceptives. Arch Pathol. 1970 Jan;89(1):1–8. [PubMed] [Google Scholar]
- Mann J. I., Vessey M. P., Thorogood M., Doll S. R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J. 1975 May 3;2(5965):241–245. doi: 10.1136/bmj.2.5965.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull. 1978 May;34(2):151–156. doi: 10.1093/oxfordjournals.bmb.a071485. [DOI] [PubMed] [Google Scholar]
- Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J. 1969 Jun 14;2(5658):651–657. doi: 10.1136/bmj.2.5658.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vessey M. P., McPherson K., Johnson B. Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet. 1977 Oct 8;2(8041):731–733. doi: 10.1016/s0140-6736(77)90236-7. [DOI] [PubMed] [Google Scholar]